COVID-19 Impact on Global Endocrine System Drug, Market Insights and Forecast to 2026
- BMR3903674
- 118 Pages
- June 2020
- Healthcare
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Endocrine System Drug industry.
Based on our recent survey, we have several different scenarios about the Endocrine System Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Endocrine System Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endocrine System Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endocrine System Drug market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Endocrine System Drug market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Endocrine System Drug market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Endocrine System Drug market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Endocrine System Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endocrine System Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endocrine System Drug market.
The following manufacturers are covered in this report:
Novo Nordisk
Sanofi
Merck
Eli Lilly
AstraZeneca
AbbVie
...
Endocrine System Drug Breakdown Data by Type
Diabetes Drug
Human Growth Hormones
Thyroid Hormone Disorder Drugs
Others
Endocrine System Drug Breakdown Data by Application
Hospital
Clinic
Medical Center
Others
1.1 Endocrine System Drug Product Introduction
1.2 Market Segments
1.3 Key Endocrine System Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Endocrine System Drug Market Size Growth Rate by Type
1.4.2 Diabetes Drug
1.4.3 Human Growth Hormones
1.4.4 Thyroid Hormone Disorder Drugs
1.4.5 Others
1.5 Market by Application
1.5.1 Global Endocrine System Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Medical Center
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Endocrine System Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Endocrine System Drug Industry
1.6.1.1 Endocrine System Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Endocrine System Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Endocrine System Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Endocrine System Drug Market Size Estimates and Forecasts
2.1.1 Global Endocrine System Drug Revenue 2015-2026
2.1.2 Global Endocrine System Drug Sales 2015-2026
2.2 Endocrine System Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Endocrine System Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Endocrine System Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Endocrine System Drug Competitor Landscape by Players
3.1 Endocrine System Drug Sales by Manufacturers
3.1.1 Endocrine System Drug Sales by Manufacturers (2015-2020)
3.1.2 Endocrine System Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Endocrine System Drug Revenue by Manufacturers
3.2.1 Endocrine System Drug Revenue by Manufacturers (2015-2020)
3.2.2 Endocrine System Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Endocrine System Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Endocrine System Drug Revenue in 2019
3.2.5 Global Endocrine System Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Endocrine System Drug Price by Manufacturers
3.4 Endocrine System Drug Manufacturing Base Distribution, Product Types
3.4.1 Endocrine System Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Endocrine System Drug Product Type
3.4.3 Date of International Manufacturers Enter into Endocrine System Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Endocrine System Drug Market Size by Type (2015-2020)
4.1.1 Global Endocrine System Drug Sales by Type (2015-2020)
4.1.2 Global Endocrine System Drug Revenue by Type (2015-2020)
4.1.3 Endocrine System Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Endocrine System Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Endocrine System Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Endocrine System Drug Revenue Forecast by Type (2021-2026)
4.2.3 Endocrine System Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Endocrine System Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Endocrine System Drug Market Size by Application (2015-2020)
5.1.1 Global Endocrine System Drug Sales by Application (2015-2020)
5.1.2 Global Endocrine System Drug Revenue by Application (2015-2020)
5.1.3 Endocrine System Drug Price by Application (2015-2020)
5.2 Endocrine System Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Endocrine System Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Endocrine System Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Endocrine System Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Endocrine System Drug by Country
6.1.1 North America Endocrine System Drug Sales by Country
6.1.2 North America Endocrine System Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Endocrine System Drug Market Facts & Figures by Type
6.3 North America Endocrine System Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Endocrine System Drug by Country
7.1.1 Europe Endocrine System Drug Sales by Country
7.1.2 Europe Endocrine System Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Endocrine System Drug Market Facts & Figures by Type
7.3 Europe Endocrine System Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Endocrine System Drug by Region
8.1.1 Asia Pacific Endocrine System Drug Sales by Region
8.1.2 Asia Pacific Endocrine System Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Endocrine System Drug Market Facts & Figures by Type
8.3 Asia Pacific Endocrine System Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Endocrine System Drug by Country
9.1.1 Latin America Endocrine System Drug Sales by Country
9.1.2 Latin America Endocrine System Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Endocrine System Drug Market Facts & Figures by Type
9.3 Central & South America Endocrine System Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Endocrine System Drug by Country
10.1.1 Middle East and Africa Endocrine System Drug Sales by Country
10.1.2 Middle East and Africa Endocrine System Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Endocrine System Drug Market Facts & Figures by Type
10.3 Middle East and Africa Endocrine System Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Endocrine System Drug Products Offered
11.1.5 Novo Nordisk Recent Development
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description, Business Overview and Total Revenue
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Endocrine System Drug Products Offered
11.2.5 Sanofi Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Endocrine System Drug Products Offered
11.3.5 Merck Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Description, Business Overview and Total Revenue
11.4.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly Endocrine System Drug Products Offered
11.4.5 Eli Lilly Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description, Business Overview and Total Revenue
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Endocrine System Drug Products Offered
11.5.5 AstraZeneca Recent Development
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Description, Business Overview and Total Revenue
11.6.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AbbVie Endocrine System Drug Products Offered
11.6.5 AbbVie Recent Development
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Endocrine System Drug Products Offered
11.1.5 Novo Nordisk Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Endocrine System Drug Market Estimates and Projections by Region
12.1.1 Global Endocrine System Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Endocrine System Drug Revenue Forecast by Regions 2021-2026
12.2 North America Endocrine System Drug Market Size Forecast (2021-2026)
12.2.1 North America: Endocrine System Drug Sales Forecast (2021-2026)
12.2.2 North America: Endocrine System Drug Revenue Forecast (2021-2026)
12.2.3 North America: Endocrine System Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Endocrine System Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Endocrine System Drug Sales Forecast (2021-2026)
12.3.2 Europe: Endocrine System Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Endocrine System Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Endocrine System Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Endocrine System Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Endocrine System Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Endocrine System Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Endocrine System Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Endocrine System Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Endocrine System Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Endocrine System Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Endocrine System Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Endocrine System Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Endocrine System Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Endocrine System Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Endocrine System Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Endocrine System Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Table 1. Endocrine System Drug Market Segments
Table 2. Ranking of Global Top Endocrine System Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Endocrine System Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diabetes Drug
Table 5. Major Manufacturers of Human Growth Hormones
Table 6. Major Manufacturers of Thyroid Hormone Disorder Drugs
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Endocrine System Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Endocrine System Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Endocrine System Drug Players to Combat Covid-19 Impact
Table 13. Global Endocrine System Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Endocrine System Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Endocrine System Drug Sales by Regions 2015-2020 (K Units)
Table 16. Global Endocrine System Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Endocrine System Drug Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Endocrine System Drug Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Endocrine System Drug Sales Share by Manufacturers (2015-2020)
Table 20. Global Endocrine System Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Endocrine System Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine System Drug as of 2019)
Table 22. Endocrine System Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Endocrine System Drug Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Endocrine System Drug Price (2015-2020) (USD/Unit)
Table 25. Endocrine System Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Endocrine System Drug Product Type
Table 27. Date of International Manufacturers Enter into Endocrine System Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Endocrine System Drug Sales by Type (2015-2020) (K Units)
Table 30. Global Endocrine System Drug Sales Share by Type (2015-2020)
Table 31. Global Endocrine System Drug Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Endocrine System Drug Revenue Share by Type (2015-2020)
Table 33. Endocrine System Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Endocrine System Drug Sales by Application (2015-2020) (K Units)
Table 35. Global Endocrine System Drug Sales Share by Application (2015-2020)
Table 36. North America Endocrine System Drug Sales by Country (2015-2020) (K Units)
Table 37. North America Endocrine System Drug Sales Market Share by Country (2015-2020)
Table 38. North America Endocrine System Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Endocrine System Drug Revenue Market Share by Country (2015-2020)
Table 40. North America Endocrine System Drug Sales by Type (2015-2020) (K Units)
Table 41. North America Endocrine System Drug Sales Market Share by Type (2015-2020)
Table 42. North America Endocrine System Drug Sales by Application (2015-2020) (K Units)
Table 43. North America Endocrine System Drug Sales Market Share by Application (2015-2020)
Table 44. Europe Endocrine System Drug Sales by Country (2015-2020) (K Units)
Table 45. Europe Endocrine System Drug Sales Market Share by Country (2015-2020)
Table 46. Europe Endocrine System Drug Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Endocrine System Drug Revenue Market Share by Country (2015-2020)
Table 48. Europe Endocrine System Drug Sales by Type (2015-2020) (K Units)
Table 49. Europe Endocrine System Drug Sales Market Share by Type (2015-2020)
Table 50. Europe Endocrine System Drug Sales by Application (2015-2020) (K Units)
Table 51. Europe Endocrine System Drug Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Endocrine System Drug Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Endocrine System Drug Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Endocrine System Drug Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Endocrine System Drug Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Endocrine System Drug Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Endocrine System Drug Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Endocrine System Drug Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Endocrine System Drug Sales Market Share by Application (2015-2020)
Table 60. Latin America Endocrine System Drug Sales by Country (2015-2020) (K Units)
Table 61. Latin America Endocrine System Drug Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Endocrine System Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Endocrine System Drug Revenue Market Share by Country (2015-2020)
Table 64. Latin America Endocrine System Drug Sales by Type (2015-2020) (K Units)
Table 65. Latin America Endocrine System Drug Sales Market Share by Type (2015-2020)
Table 66. Latin America Endocrine System Drug Sales by Application (2015-2020) (K Units)
Table 67. Latin America Endocrine System Drug Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Endocrine System Drug Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Endocrine System Drug Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Endocrine System Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Endocrine System Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Endocrine System Drug Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Endocrine System Drug Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Endocrine System Drug Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Endocrine System Drug Sales Market Share by Application (2015-2020)
Table 76. Novo Nordisk Corporation Information
Table 77. Novo Nordisk Description and Major Businesses
Table 78. Novo Nordisk Endocrine System Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Novo Nordisk Product
Table 80. Novo Nordisk Recent Development
Table 81. Sanofi Corporation Information
Table 82. Sanofi Description and Major Businesses
Table 83. Sanofi Endocrine System Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Sanofi Product
Table 85. Sanofi Recent Development
Table 86. Merck Corporation Information
Table 87. Merck Description and Major Businesses
Table 88. Merck Endocrine System Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Merck Product
Table 90. Merck Recent Development
Table 91. Eli Lilly Corporation Information
Table 92. Eli Lilly Description and Major Businesses
Table 93. Eli Lilly Endocrine System Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Eli Lilly Product
Table 95. Eli Lilly Recent Development
Table 96. AstraZeneca Corporation Information
Table 97. AstraZeneca Description and Major Businesses
Table 98. AstraZeneca Endocrine System Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. AstraZeneca Product
Table 100. AstraZeneca Recent Development
Table 101. AbbVie Corporation Information
Table 102. AbbVie Description and Major Businesses
Table 103. AbbVie Endocrine System Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. AbbVie Product
Table 105. AbbVie Recent Development
Table 106. Global Endocrine System Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 107. Global Endocrine System Drug Sales Market Share Forecast by Regions (2021-2026)
Table 108. Global Endocrine System Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 109. Global Endocrine System Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 110. North America: Endocrine System Drug Sales Forecast by Country (2021-2026) (K Units)
Table 111. North America: Endocrine System Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Europe: Endocrine System Drug Sales Forecast by Country (2021-2026) (K Units)
Table 113. Europe: Endocrine System Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Asia Pacific: Endocrine System Drug Sales Forecast by Region (2021-2026) (K Units)
Table 115. Asia Pacific: Endocrine System Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 116. Latin America: Endocrine System Drug Sales Forecast by Country (2021-2026) (K Units)
Table 117. Latin America: Endocrine System Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Middle East and Africa: Endocrine System Drug Sales Forecast by Country (2021-2026) (K Units)
Table 119. Middle East and Africa: Endocrine System Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Main Points Interviewed from Key Endocrine System Drug Players
Table 124. Endocrine System Drug Customers List
Table 125. Endocrine System Drug Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Endocrine System Drug Product Picture
Figure 2. Global Endocrine System Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Diabetes Drug Product Picture
Figure 4. Human Growth Hormones Product Picture
Figure 5. Thyroid Hormone Disorder Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Endocrine System Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Medical Center
Figure 11. Others
Figure 12. Endocrine System Drug Report Years Considered
Figure 13. Global Endocrine System Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Endocrine System Drug Sales 2015-2026 (K Units)
Figure 15. Global Endocrine System Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Endocrine System Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Endocrine System Drug Sales Market Share by Region in 2019
Figure 18. Global Endocrine System Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Endocrine System Drug Revenue Market Share by Region in 2019
Figure 20. Global Endocrine System Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Endocrine System Drug Revenue in 2019
Figure 22. Endocrine System Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Endocrine System Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Endocrine System Drug Sales Market Share by Type in 2019
Figure 25. Global Endocrine System Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Endocrine System Drug Revenue Market Share by Type in 2019
Figure 27. Global Endocrine System Drug Market Share by Price Range (2015-2020)
Figure 28. Global Endocrine System Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Endocrine System Drug Sales Market Share by Application in 2019
Figure 30. Global Endocrine System Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Endocrine System Drug Revenue Market Share by Application in 2019
Figure 32. North America Endocrine System Drug Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Endocrine System Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Endocrine System Drug Sales Market Share by Country in 2019
Figure 35. North America Endocrine System Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Endocrine System Drug Market Share by Type in 2019
Figure 41. North America Endocrine System Drug Market Share by Application in 2019
Figure 42. Europe Endocrine System Drug Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Endocrine System Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Endocrine System Drug Sales Market Share by Country in 2019
Figure 45. Europe Endocrine System Drug Revenue Market Share by Country in 2019
Figure 46. Germany Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Endocrine System Drug Market Share by Type in 2019
Figure 57. Europe Endocrine System Drug Market Share by Application in 2019
Figure 58. Asia Pacific Endocrine System Drug Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Endocrine System Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Endocrine System Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Endocrine System Drug Revenue Market Share by Region in 2019
Figure 62. China Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Endocrine System Drug Market Share by Type in 2019
Figure 85. Asia Pacific Endocrine System Drug Market Share by Application in 2019
Figure 86. Latin America Endocrine System Drug Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Endocrine System Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Endocrine System Drug Sales Market Share by Country in 2019
Figure 89. Latin America Endocrine System Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Endocrine System Drug Market Share by Type in 2019
Figure 97. Latin America Endocrine System Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Endocrine System Drug Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Endocrine System Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Endocrine System Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Endocrine System Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Endocrine System Drug Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Endocrine System Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Endocrine System Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Endocrine System Drug Market Share by Application in 2019
Figure 110. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Endocrine System Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. North America Endocrine System Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Endocrine System Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Europe Endocrine System Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Endocrine System Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Asia Pacific Endocrine System Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Endocrine System Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Latin America Endocrine System Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Endocrine System Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Middle East and Africa Endocrine System Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
